基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 尼卡普醇 尼卡普醇
  • 尼卡普醇|T4539|TargetMol

尼卡普醇|T4539|TargetMol

Nicainoprol
76252-06-7
1080 1mg 起订
2790 5mg 起订
3970 10mg 起订
上海 更新日期:2024-12-12

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
尼卡普醇
英文名称:
Nicainoprol
CAS号:
76252-06-7
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
100%
产品类别:
抑制剂
货号:
T4539

Product Introduction

Bioactivity

名称Nicainoprol
描述Nicainoprol (RU-42924) is a fast-sodium-channel blocking drug. Nicainoprol is a potent antiarrhythmic agent.
体外活性The antiarrhythmic agent Nicainoprol is a fast-sodium-channel blocking drug that also protects isolated rat hearts against reperfusion arrhythmias. However, it is without beneficial effects on cardiac hemodynamics and biochemical parameters, in contrast to the ACE inhibitor[1].
体内活性The effect of the novel antiarrhythmic agent Nicainoprol on coronary occlusion and reperfusion arrhythmia is investigated in isolated working rat hearts and in anesthetized rats. Nicainoprol (10 μM, 5 μM and 100 μM) in isolated working rat hearts induces concentration-related protection against reperfusion arrhythmia without changing the cardiodynamics while the exception of a decrease in heart rate at the highest concentration. Enzyme levels (lactate dehydrogenase and creatine kinase) in the coronary venous effluent, and cardiac tissue concentrations of glycogen, lactate, ATP and creatine phosphate are not affected by Nicainoprol. Given to anesthetized rats, Nicainoprol (5 and 10 mg/kg i.v.) reduces dose dependently in the early post occlusion (0-30 min) period, the percentage of animals with premature ventricular complexes (PVCs) and ventricular tachycardia while completely preventing the occurrence of ventricular fibrillation. In the reperfusion period no animal treated with 5 mg/kg and 12% of the rats treated with 10 mg/kg showed PVCs (the only form of arrhythmia observed in this period) versus 60% of the control rats. Both doses of Nicainoprol induces a decrease in heart rate, blood pressure and myocardial oxygen consumption. The ratio of infarct mass to ventricular mass is significantly reduced by 20% at a dose of 5 mg/kg and by 28% at the dose of 10 mg/kg. Nicainoprol could be useful in the prevention and treatment of arrhythmias associated with acute myocardial infarction[2].
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 55 mg/mL (148.87 mM)
关键字Na+ channels | inhibit | Sodium Channel | Inhibitor | Na channels | Nicainoprol | RU 42924 | RU42924
相关产品Lidocaine hydrochloride | Benzocaine | Valproic Acid | Lidocaine | Mebeverine hydrochloride | Safinamide | Procaine | Amitriptyline hydrochloride | L-Aspartic aicd sodium | Lidocaine Hydrochloride hydrate | Riluzole | Phenytoin sodium
相关库神经保护化合物库 | 抑制剂库 | 经典已知活性库 | 抗癌化合物库 | 已知活性化合物库 | NO PAINS 化合物库 | 离子通道库 | 膜蛋白靶向化合物库 | 疼痛相关化合物库 | 表型筛选靶点鉴定库
尼卡普醇|||RU-42924|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

尼卡普醇相关厂家报价

  • 妥卡尼
  • 妥卡尼
  • 陕西缔都医药化工有限公司 VIP
  • 2024-12-18
  • 询价
  • 卡普坦
  • 卡普坦
  • 陕西缔都医药化工有限公司 VIP
  • 2024-12-18
  • 询价
内容声明
拨打电话 立即询价